Peptide dosing
With peptides and GLP-1 medications, dose is most of the story: how much, how often, how to step up without inviting side effects, and how to reconstitute a vial correctly. These articles collect what we've written on peptide dosing — titration schedules, injection frequency, microdosing debates, and technique.
One thing you won't find is a personal protocol: that's your prescriber's job. Every Promise treatment comes with provider oversight, and dosing decisions belong in that conversation. Where a compound has its own dosing article, you'll find the specifics there.
72 articles on this topic
-
Egrifta Prescribing Information, Explained
Egrifta WR’s label covers one HIV-related use, a daily dose, four contraindications, monitoring, side effects, and product-specific storage. WR and SV directions cannot be swapped.
-
What Is Dose Titration? Why Doses Change in Steps
Dose titration means changing a dose in steps while checking response and side effects. A gradual climb has a purpose, and the highest dose isn’t everyone’s destination.
-
Tirzepatide and Thyroid: Levothyroxine Checks
An underactive thyroid doesn't automatically rule out tirzepatide. Weight loss and changes in tablet absorption can make a thyroid-dose review worthwhile.
-
Forzinity Prescribing Information: Plain English
Forzinity’s label covers Barth syndrome, a daily injection, and specific safety limits. Here’s what each section means.
-
Vyleesi Prescribing Information, in Plain English
Vyleesi's label covers one specific form of low desire, a fixed injection dose, and safety limits. Here are its sections in everyday language.
-
Ozempic Prescribing Information, Explained
The Ozempic injection label, revised May 2026, covers three type 2 diabetes uses, a 0.25 mg to 2 mg dose ladder, the thyroid boxed warning, side-effect rates and storage. Here it is in plain words.
-
Switching From Wegovy Injection to Pill: New Data
Today's OCTANE results found an average 4.1% weight loss three months after switching to the Wegovy pill. The selected group and short follow-up matter when reading that number.
-
Mounjaro Prescribing Information, Explained
The current Mounjaro label is revised August 2026. It added a heart-risk use, stopped calling 2.5 mg a starter-only dose, and reworded an eye warning. Here is the whole document in plain words.
-
VK2735: Monthly Shots Held Most Weight Off, So Far
Viking says people kept most of their weight loss after moving from weekly VK2735 shots to monthly ones. What the 12-week study shows, what it can't tell you yet, and what it means for tirzepatide.
-
Wegovy Prescribing Information, Explained
The current Wegovy label is revised June 2026. It covers weight, cardiovascular and MASH uses; the injection dose ladder including 7.2 mg; the boxed warning; common reactions; pregnancy; and device formats.
-
Zepbound Prescribing Information, Explained
The current label is revised August 2026. It covers two uses, a weekly dose ladder, two absolute contraindications, the boxed thyroid warning, common stomach side effects, pregnancy, and four delivery formats.
-
Kisspeptin Dose: What Human Studies Actually Used
There is no standard kisspeptin dose to copy from a study. Human trials used different peptide forms, routes, and schedules, so a prescription has to be set for the person and the clinical goal.
-
Where to Inject CJC-1295 Ipamorelin: Site Guide
CJC-1295/ipamorelin is generally given into fatty tissue just under the skin. Common areas include the abdomen, thigh, back of the upper arm, and upper buttock, but the pharmacy label sets the sites for the exact prescription.
-
PT-141 Half-Life Is About 2.7 Hours
The number is short, but it is not a stopwatch for how long someone feels an effect. Here is what the label's timing, clearance range, and safety limits actually mean.
-
TB-500 10 mg: What the Vial Size Really Means
A 10 mg mark states the total peptide mass the vial is meant to contain. It is not a per-injection dose, a concentration, or proof that an unverified vial contains what its label claims.
-
PT-141 10mg Vial: What That Number Means
Ten milligrams describes what is in the whole vial. It does not tell you what to draw up, how many uses you have, or how a nasal product compares; those answers come from the prescription and pharmacy label.
-
Sermorelin Half-Life: Minutes, Not Hours
Sermorelin leaves the bloodstream in minutes, but the growth-hormone pulse it starts can last for hours. Those are two different clocks, and neither is a personal dosing or drug-testing deadline.
-
Where to Inject MOTS-c: What the Evidence Says
The available human trial records point to a subcutaneous shot into the fatty layer beneath the skin. The pharmacy label and prescriber—not an online injection map—set the site for a specific MOTS-c preparation.
-
SS-31 Protocol: What the Trials Actually Used
There is no single SS-31 cycle supported by human research. The useful evidence is narrower: a labeled plan for one rare disease and several trial schedules that cannot be copied into personal dosing advice.
-
When to Take Sermorelin: Why Bedtime Is Common
Bedtime is the usual convention because the body's largest growth-hormone pulse often follows deep sleep. It is a rhythm to work with, not proof that one clock time fits everyone.
Page 1 of 4 · 72 articles